Effector Therapeutics shares owned by Blackstone Group
Quarter-by-quarter ownership of Effector Therapeutics shares owned by Blackstone Group
from 13F filings
Historical chart of Blackstone Group investment in Effector Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Effector Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Effector Therapeutics by Blackstone Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $612k | 1.3M | 0.47 |
| 2023-09-30 | $785k | 1.3M | 0.60 |
| 2023-06-30 | $1.1M | 1.3M | 0.83 |
| 2023-03-31 | $462k | 1.3M | 0.35 |
| 2022-12-31 | $560k | 1.3M | 0.43 |
| 2022-09-30 | $749k | 1.3M | 0.57 |
| 2022-06-30 | $1.9M | 1.3M | 1.42 |
| 2022-03-31 | $5.2M | 1.3M | 4.01 |
| 2021-12-31 | $7.8M | 1.3M | 5.96 |
| 2021-09-30 | $18M | 1.3M | 14.05 |